APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epoetin (Eritropoyetin)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Epoetin (Eritropoyetin) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025190 pages

Choose your research edition.

Industry ResearchEpoetin (Eritropoyetin) Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Epoetin (Eritropoyetin) Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Epoetin (Eritropoyetin) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epoetin (Eritropoyetin) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Epoetin (Eritropoyetin) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Epoetin (Eritropoyetin) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Epoetin (Eritropoyetin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Epoetin (Eritropoyetin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epoetin (Eritropoyetin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Epoetin (Eritropoyetin) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Epoetin (Eritropoyetin) include Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Roche, Amgen, Ranbaxy Laboratories Ltd, LG Life Sciences Ltd, Intas Pharmaceuticals, Hospira Inc and Epoetin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Epoetin (Eritropoyetin) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Epoetin (Eritropoyetin) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Epoetin (Eritropoyetin) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Epoetin (Eritropoyetin) market size, projected growth trends, production technologies, key applications, and end-use industries.

Epoetin (Eritropoyetin) Segment by Company

Teva Pharmaceutical Industries Ltd

Johnson & Johnson

Roche

Amgen

Ranbaxy Laboratories Ltd

LG Life Sciences Ltd

Intas Pharmaceuticals

Hospira Inc

Epoetin

Celltrion, Inc

Biocon

Abcam

Epoetin (Eritropoyetin) Segment by Type

Epoetin-beta

Epoetin-alfa

Darbepoetin Alfa

Epoetin (Eritropoyetin) Segment by Application

Anemia (Cancer and HIV Treatment)

Kidney Disorders (ESRD and Dialysis)

Others (Neural Disease and Wound Healing)

Epoetin (Eritropoyetin) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epoetin (Eritropoyetin) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epoetin (Eritropoyetin) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epoetin (Eritropoyetin).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Epoetin (Eritropoyetin) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Epoetin (Eritropoyetin) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Epoetin (Eritropoyetin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Epoetin (Eritropoyetin) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Epoetin (Eritropoyetin) Industry Trends Table 2. Epoetin (Eritropoyetin) Industry Drivers Table 3. Epoetin (Eritropoyetin) Industry Opportunities and Challenges Table 4. Epoetin (Eritropoyetin) Industry Restraints Table 5. Global Epoetin (Eritropoyetin) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Epoetin (Eritropoyetin) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Epoetin (Eritropoyetin) Sales by Manufacturers (units) & (2021-2026) Table 8. Global Epoetin (Eritropoyetin) Sales Market Share by Manufacturers Table 9. Global Epoetin (Eritropoyetin) Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Epoetin (Eritropoyetin) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Epoetin (Eritropoyetin) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Epoetin (Eritropoyetin) Manufacturers, Product Type & Application Table 13. Global Epoetin (Eritropoyetin) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Epoetin (Eritropoyetin) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Epoetin-beta Table 17. Major Manufacturers of Epoetin-alfa Table 18. Major Manufacturers of Darbepoetin Alfa Table 19. Global Epoetin (Eritropoyetin) Sales by Type 2021 VS 2025 VS 2032 (units) Table 20. Global Epoetin (Eritropoyetin) Sales by Type (2021-2026) & (units) Table 21. Global Epoetin (Eritropoyetin) Sales by Type (2027-2032) & (units) Table 22. Global Epoetin (Eritropoyetin) Sales Market Share by Type (2021-2026) Table 23. Global Epoetin (Eritropoyetin) Sales Market Share by Type (2027-2032) Table 24. Global Epoetin (Eritropoyetin) Revenue by Type 2021 VS 2025 VS 2032 (units) Table 25. Global Epoetin (Eritropoyetin) Revenue by Type (2021-2026) & (units) Table 26. Global Epoetin (Eritropoyetin) Revenue by Type (2027-2032) & (units) Table 27. Global Epoetin (Eritropoyetin) Revenue Market Share by Type (2021-2026) Table 28. Global Epoetin (Eritropoyetin) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Anemia (Cancer and HIV Treatment) Table 30. Major Manufacturers of Kidney Disorders (ESRD and Dialysis) Table 31. Major Manufacturers of Others (Neural Disease and Wound Healing) Table 32. Global Epoetin (Eritropoyetin) Sales by Application 2021 VS 2025 VS 2032 (units) Table 33. Global Epoetin (Eritropoyetin) Sales by Application (2021-2026) & (units) Table 34. Global Epoetin (Eritropoyetin) Sales by Application (2027-2032) & (units) Table 35. Global Epoetin (Eritropoyetin) Sales Market Share by Application (2021-2026) Table 36. Global Epoetin (Eritropoyetin) Sales Market Share by Application (2027-2032) Table 37. Global Epoetin (Eritropoyetin) Revenue by Application 2021 VS 2025 VS 2032 (units) Table 38. Global Epoetin (Eritropoyetin) Revenue by Application (2021-2026) & (units) Table 39. Global Epoetin (Eritropoyetin) Revenue by Application (2027-2032) & (units) Table 40. Global Epoetin (Eritropoyetin) Revenue Market Share by Application (2021-2026) Table 41. Global Epoetin (Eritropoyetin) Revenue Market Share by Application (2027-2032) Table 42. Global Epoetin (Eritropoyetin) Sales by Region: 2021 VS 2025 VS 2032 (units) Table 43. Global Epoetin (Eritropoyetin) Sales by Region (2021-2026) & (units) Table 44. Global Epoetin (Eritropoyetin) Sales Market Share by Region (2021-2026) Table 45. Global Epoetin (Eritropoyetin) Sales Forecasted by Region (2027-2032) & (units) Table 46. Global Epoetin (Eritropoyetin) Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Epoetin (Eritropoyetin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 48. North America Epoetin (Eritropoyetin) Sales by Country (2021-2026) & (units) Table 49. North America Epoetin (Eritropoyetin) Sales by Country (2027-2032) & (units) Table 50. Europe Epoetin (Eritropoyetin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 51. Europe Epoetin (Eritropoyetin) Sales by Country (2021-2026) & (units) Table 52. Europe Epoetin (Eritropoyetin) Sales by Country (2027-2032) & (units) Table 53. Asia Pacific Epoetin (Eritropoyetin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 54. Asia Pacific Epoetin (Eritropoyetin) Sales by Country (2021-2026) & (units) Table 55. Asia Pacific Epoetin (Eritropoyetin) Sales by Country (2027-2032) & (units) Table 56. South America, Middle East and Africa Epoetin (Eritropoyetin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (units) Table 57. South America, Middle East and Africa Epoetin (Eritropoyetin) Sales by Country (2021-2026) & (units) Table 58. South America, Middle East and Africa Epoetin (Eritropoyetin) Sales by Country (2027-2032) & (units) Table 59. Global Epoetin (Eritropoyetin) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Epoetin (Eritropoyetin) Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Epoetin (Eritropoyetin) Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Epoetin (Eritropoyetin) Revenue Market Share by Region (2021-2026) Table 63. Global Epoetin (Eritropoyetin) Revenue Market Share by Region (2027-2032) Table 64. Teva Pharmaceutical Industries Ltd Company Information Table 65. Teva Pharmaceutical Industries Ltd Business Overview Table 66. Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Product Portfolio Table 68. Teva Pharmaceutical Industries Ltd Recent Development Table 69. Johnson & Johnson Company Information Table 70. Johnson & Johnson Business Overview Table 71. Johnson & Johnson Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Johnson & Johnson Epoetin (Eritropoyetin) Product Portfolio Table 73. Johnson & Johnson Recent Development Table 74. Roche Company Information Table 75. Roche Business Overview Table 76. Roche Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Roche Epoetin (Eritropoyetin) Product Portfolio Table 78. Roche Recent Development Table 79. Amgen Company Information Table 80. Amgen Business Overview Table 81. Amgen Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Amgen Epoetin (Eritropoyetin) Product Portfolio Table 83. Amgen Recent Development Table 84. Ranbaxy Laboratories Ltd Company Information Table 85. Ranbaxy Laboratories Ltd Business Overview Table 86. Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Product Portfolio Table 88. Ranbaxy Laboratories Ltd Recent Development Table 89. LG Life Sciences Ltd Company Information Table 90. LG Life Sciences Ltd Business Overview Table 91. LG Life Sciences Ltd Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. LG Life Sciences Ltd Epoetin (Eritropoyetin) Product Portfolio Table 93. LG Life Sciences Ltd Recent Development Table 94. Intas Pharmaceuticals Company Information Table 95. Intas Pharmaceuticals Business Overview Table 96. Intas Pharmaceuticals Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Intas Pharmaceuticals Epoetin (Eritropoyetin) Product Portfolio Table 98. Intas Pharmaceuticals Recent Development Table 99. Hospira Inc Company Information Table 100. Hospira Inc Business Overview Table 101. Hospira Inc Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hospira Inc Epoetin (Eritropoyetin) Product Portfolio Table 103. Hospira Inc Recent Development Table 104. Epoetin Company Information Table 105. Epoetin Business Overview Table 106. Epoetin Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Epoetin Epoetin (Eritropoyetin) Product Portfolio Table 108. Epoetin Recent Development Table 109. Celltrion, Inc Company Information Table 110. Celltrion, Inc Business Overview Table 111. Celltrion, Inc Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Celltrion, Inc Epoetin (Eritropoyetin) Product Portfolio Table 113. Celltrion, Inc Recent Development Table 114. Biocon Company Information Table 115. Biocon Business Overview Table 116. Biocon Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Biocon Epoetin (Eritropoyetin) Product Portfolio Table 118. Biocon Recent Development Table 119. Abcam Company Information Table 120. Abcam Business Overview Table 121. Abcam Epoetin (Eritropoyetin) Sales (units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Abcam Epoetin (Eritropoyetin) Product Portfolio Table 123. Abcam Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Epoetin (Eritropoyetin) Distributors List Table 127. Epoetin (Eritropoyetin) Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Epoetin (Eritropoyetin) Product Image Figure 2. Global Epoetin (Eritropoyetin) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epoetin (Eritropoyetin) Market Size (2021-2032) & (US$ Million) Figure 4. Global Epoetin (Eritropoyetin) Sales (2021-2032) & (units) Figure 5. Global Epoetin (Eritropoyetin) Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Epoetin (Eritropoyetin) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Epoetin-beta Image Figure 9. Epoetin-alfa Image Figure 10. Darbepoetin Alfa Image Figure 11. Global Epoetin (Eritropoyetin) Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 12. Global Epoetin (Eritropoyetin) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Epoetin (Eritropoyetin) Sales Market Share by Type (2021-2032) Figure 14. Global Epoetin (Eritropoyetin) Revenue by Type (2021 VS 2025 VS 2032) & (units) Figure 15. Global Epoetin (Eritropoyetin) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Epoetin (Eritropoyetin) Revenue Market Share by Type (2021-2032) Figure 17. Anemia (Cancer and HIV Treatment) Image Figure 18. Kidney Disorders (ESRD and Dialysis) Image Figure 19. Others (Neural Disease and Wound Healing) Image Figure 20. Global Epoetin (Eritropoyetin) Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 21. Global Epoetin (Eritropoyetin) Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Epoetin (Eritropoyetin) Sales Market Share by Application (2021-2032) Figure 23. Global Epoetin (Eritropoyetin) Revenue by Application (2021 VS 2025 VS 2032) & (units) Figure 24. Global Epoetin (Eritropoyetin) Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Epoetin (Eritropoyetin) Revenue Market Share by Application (2021-2032) Figure 26. North America Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 27. North America Epoetin (Eritropoyetin) Sales Market Share by Country (2021-2032) Figure 28. U.S. Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 29. Canada Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 30. Mexico Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 31. Europe Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 32. Europe Epoetin (Eritropoyetin) Sales Market Share by Country (2021-2032) Figure 33. Germany Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 34. France Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 35. U.K. Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 36. Italy Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 37. Netherlands Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 38. Asia Pacific Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 39. Asia Pacific Epoetin (Eritropoyetin) Sales Market Share by Country (2021-2032) Figure 40. China Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 41. Japan Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 42. South Korea Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 43. Southeast Asia Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 44. India Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 45. Australia Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 46. South America, Middle East and Africa Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 47. South America, Middle East and Africa Epoetin (Eritropoyetin) Sales Market Share by Country (2021-2032) Figure 48. Brazil Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 49. South Africa Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 50. Saudi Arabia Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 51. Turkey Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 52. Argentina Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 53. UAE Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 54. Egypt Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 55. Chile Epoetin (Eritropoyetin) Sales and Growth Rate (2021-2032) & (units) Figure 56. Global Epoetin (Eritropoyetin) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Epoetin (Eritropoyetin) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Epoetin (Eritropoyetin) Revenue (2021-2032) & (US$ Million) Figure 59. North America Epoetin (Eritropoyetin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Epoetin (Eritropoyetin) Revenue (2021-2032) & (US$ Million) Figure 61. Europe Epoetin (Eritropoyetin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Epoetin (Eritropoyetin) Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Epoetin (Eritropoyetin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Epoetin (Eritropoyetin) Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Epoetin (Eritropoyetin) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Epoetin (Eritropoyetin) Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Epoetin (Eritropoyetin) Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Epoetin-beta
  • Epoetin-alfa
  • Darbepoetin Alfa
Applications
  • Anemia (Cancer and HIV Treatment)
  • Kidney Disorders (ESRD and Dialysis)
  • Others (Neural Disease and Wound Healing)
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Johnson & Johnson
  • Roche
  • Amgen
  • Ranbaxy Laboratories Ltd
  • LG Life Sciences Ltd
  • Intas Pharmaceuticals
  • Hospira Inc
  • Epoetin
  • Celltrion, Inc
  • Biocon
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Epoetin (Eritropoyetin) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Epoetin (Eritropoyetin) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Epoetin (Eritropoyetin) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Epoetin (Eritropoyetin) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Epoetin (Eritropoyetin) Market Dynamics
  1. 2.1 Epoetin (Eritropoyetin) Industry Trends
  2. 2.2 Epoetin (Eritropoyetin) Industry Drivers
  3. 2.3 Epoetin (Eritropoyetin) Industry Opportunities and Challenges
  4. 2.4 Epoetin (Eritropoyetin) Industry Restraints
3 Epoetin (Eritropoyetin) Market by Manufacturers
  1. 3.1 Global Epoetin (Eritropoyetin) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Epoetin (Eritropoyetin) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Epoetin (Eritropoyetin) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Epoetin (Eritropoyetin) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Epoetin (Eritropoyetin) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Epoetin (Eritropoyetin) Manufacturers, Product Type & Application
  7. 3.7 Global Epoetin (Eritropoyetin) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Epoetin (Eritropoyetin) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Epoetin (Eritropoyetin) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Epoetin (Eritropoyetin) Tier 1, Tier 2, and Tier 3
4 Epoetin (Eritropoyetin) Market by Type
  1. 4.1 Epoetin (Eritropoyetin) Type Introduction
  2. 4.1.1 Epoetin-beta
  3. 4.1.2 Epoetin-alfa
  4. 4.1.3 Darbepoetin Alfa
  5. 4.2 Global Epoetin (Eritropoyetin) Sales by Type
  6. 4.2.1 Global Epoetin (Eritropoyetin) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Epoetin (Eritropoyetin) Sales by Type (2021-2032)
  8. 4.2.3 Global Epoetin (Eritropoyetin) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Epoetin (Eritropoyetin) Revenue by Type
  10. 4.3.1 Global Epoetin (Eritropoyetin) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Epoetin (Eritropoyetin) Revenue by Type (2021-2032)
  12. 4.3.3 Global Epoetin (Eritropoyetin) Revenue Market Share by Type (2021-2032)
5 Epoetin (Eritropoyetin) Market by Application
  1. 5.1 Epoetin (Eritropoyetin) Application Introduction
  2. 5.1.1 Anemia (Cancer and HIV Treatment)
  3. 5.1.2 Kidney Disorders (ESRD and Dialysis)
  4. 5.1.3 Others (Neural Disease and Wound Healing)
  5. 5.2 Global Epoetin (Eritropoyetin) Sales by Application
  6. 5.2.1 Global Epoetin (Eritropoyetin) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Epoetin (Eritropoyetin) Sales by Application (2021-2032)
  8. 5.2.3 Global Epoetin (Eritropoyetin) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Epoetin (Eritropoyetin) Revenue by Application
  10. 5.3.1 Global Epoetin (Eritropoyetin) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Epoetin (Eritropoyetin) Revenue by Application (2021-2032)
  12. 5.3.3 Global Epoetin (Eritropoyetin) Revenue Market Share by Application (2021-2032)
6 Global Epoetin (Eritropoyetin) Sales by Region
  1. 6.1 Global Epoetin (Eritropoyetin) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Epoetin (Eritropoyetin) Sales by Region (2021-2032)
  3. 6.2.1 Global Epoetin (Eritropoyetin) Sales by Region (2021-2026)
  4. 6.2.2 Global Epoetin (Eritropoyetin) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Epoetin (Eritropoyetin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Epoetin (Eritropoyetin) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Epoetin (Eritropoyetin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Epoetin (Eritropoyetin) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Epoetin (Eritropoyetin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Epoetin (Eritropoyetin) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Epoetin (Eritropoyetin) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Epoetin (Eritropoyetin) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Epoetin (Eritropoyetin) Revenue by Region
  1. 7.1 Global Epoetin (Eritropoyetin) Revenue by Region
  2. 7.1.1 Global Epoetin (Eritropoyetin) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Epoetin (Eritropoyetin) Revenue by Region (2021-2026)
  4. 7.1.3 Global Epoetin (Eritropoyetin) Revenue by Region (2027-2032)
  5. 7.1.4 Global Epoetin (Eritropoyetin) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Epoetin (Eritropoyetin) Revenue (2021-2032)
  8. 7.2.2 North America Epoetin (Eritropoyetin) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Epoetin (Eritropoyetin) Revenue (2021-2032)
  11. 7.3.2 Europe Epoetin (Eritropoyetin) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Epoetin (Eritropoyetin) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Epoetin (Eritropoyetin) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Epoetin (Eritropoyetin) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Epoetin (Eritropoyetin) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries Ltd
  2. 8.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Ltd Epoetin (Eritropoyetin) Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Epoetin (Eritropoyetin) Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Epoetin (Eritropoyetin) Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Amgen
  20. 8.4.1 Amgen Company Information
  21. 8.4.2 Amgen Business Overview
  22. 8.4.3 Amgen Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Amgen Epoetin (Eritropoyetin) Product Portfolio
  24. 8.4.5 Amgen Recent Developments
  25. 8.5 Ranbaxy Laboratories Ltd
  26. 8.5.1 Ranbaxy Laboratories Ltd Company Information
  27. 8.5.2 Ranbaxy Laboratories Ltd Business Overview
  28. 8.5.3 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ranbaxy Laboratories Ltd Epoetin (Eritropoyetin) Product Portfolio
  30. 8.5.5 Ranbaxy Laboratories Ltd Recent Developments
  31. 8.6 LG Life Sciences Ltd
  32. 8.6.1 LG Life Sciences Ltd Company Information
  33. 8.6.2 LG Life Sciences Ltd Business Overview
  34. 8.6.3 LG Life Sciences Ltd Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LG Life Sciences Ltd Epoetin (Eritropoyetin) Product Portfolio
  36. 8.6.5 LG Life Sciences Ltd Recent Developments
  37. 8.7 Intas Pharmaceuticals
  38. 8.7.1 Intas Pharmaceuticals Company Information
  39. 8.7.2 Intas Pharmaceuticals Business Overview
  40. 8.7.3 Intas Pharmaceuticals Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Intas Pharmaceuticals Epoetin (Eritropoyetin) Product Portfolio
  42. 8.7.5 Intas Pharmaceuticals Recent Developments
  43. 8.8 Hospira Inc
  44. 8.8.1 Hospira Inc Company Information
  45. 8.8.2 Hospira Inc Business Overview
  46. 8.8.3 Hospira Inc Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hospira Inc Epoetin (Eritropoyetin) Product Portfolio
  48. 8.8.5 Hospira Inc Recent Developments
  49. 8.9 Epoetin
  50. 8.9.1 Epoetin Company Information
  51. 8.9.2 Epoetin Business Overview
  52. 8.9.3 Epoetin Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Epoetin Epoetin (Eritropoyetin) Product Portfolio
  54. 8.9.5 Epoetin Recent Developments
  55. 8.10 Celltrion, Inc
  56. 8.10.1 Celltrion, Inc Company Information
  57. 8.10.2 Celltrion, Inc Business Overview
  58. 8.10.3 Celltrion, Inc Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Celltrion, Inc Epoetin (Eritropoyetin) Product Portfolio
  60. 8.10.5 Celltrion, Inc Recent Developments
  61. 8.11 Biocon
  62. 8.11.1 Biocon Company Information
  63. 8.11.2 Biocon Business Overview
  64. 8.11.3 Biocon Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biocon Epoetin (Eritropoyetin) Product Portfolio
  66. 8.11.5 Biocon Recent Developments
  67. 8.12 Abcam
  68. 8.12.1 Abcam Company Information
  69. 8.12.2 Abcam Business Overview
  70. 8.12.3 Abcam Epoetin (Eritropoyetin) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Abcam Epoetin (Eritropoyetin) Product Portfolio
  72. 8.12.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Epoetin (Eritropoyetin) Value Chain Analysis
  2. 9.1.1 Epoetin (Eritropoyetin) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Epoetin (Eritropoyetin) Production Mode & Process
  6. 9.2 Epoetin (Eritropoyetin) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Epoetin (Eritropoyetin) Distributors
  9. 9.2.3 Epoetin (Eritropoyetin) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst